Dear , Welcome to the latest issue of the HealthCapital newsletter,

What was once considered a black box is rapidly becoming intelligible: contemporary neuroscience reveals how we think, learn, decide, and regulate emotions – unlocking new pathways for prevention, therapy, AI, and innovative work environments. 

The German capital region Berlin-Brandenburg continues to gain momentum in this field. This is particularly evident in the renewal of the Einstein Professorship for Prof. Surjo Soekadar, which will enable the establishment of a NeuroTech Open Innovation Hub at Charité. The goal here is to bring clinical neurotechnology into patient care more quickly, such as modern brain-computer interfaces for people with motor or cognitive impairments. You can learn more about these developments in our interview with Prof. Soekadar. 

At the same time, Berlin’s research ecosystem demonstrates an extraordinary breadth of topics and scientific depth. At the Berlin Institute of Health, Johanna Quandt-Professor Petra Ritter is working to improve diagnostics and therapy for diseases such as Alzheimer’s, stroke, and epilepsy with the help of brain simulations.  

The new OPM-MEG Center at Charité and the Physikalisch-Technische Bundesanstalt opens up new possibilities for a more precise understanding of psychiatric and neurological disorders. The NeuroCure Cluster of Excellence has been conducting interdisciplinary research into the fundamentals of neurological and psychiatric disorders for many years and enjoys international appeal. And with the EU project NerveRepack, Fraunhofer IZM is advancing new neurotechnological solutions for people with amputated or paralyzed limbs. 

Our companies are also making a strong impact. The startup Nuuron is developing a fully digital Alzheimer’s therapy based on neuromodulatory technologies and has secured significant investments for this purpose. At the same time, eemagine, a long-established Berlin-based company, is a global leader in EEG and neuronavigation systems. 

Recent developments clearly show that neuroscience is one of the key innovation fields of the future—and Berlin-Brandenburg is among its most important hubs. Research, clinical application, and economic dynamism are closely intertwined here, creating an ecosystem that sets international standards. 

Your 
Dr. Kai Bindseil 
Berlin Partner for Business and Technology